Schachter M

No ORCID on file · 2 papers in corpus
article 2010
Journal of controlled release : official journal of the Controlled Release Society ·doi:10.1016/j.jconrel.2010.08.030

Innate immunity and inflammation are of major importance in various pathological conditions. Intravenous (IV) and intraperitoneal (IP) liposomal alendronate (LA) treatments have been shown to deplete circulating monocytes and peritoneal mac…

article 2008
Human Reproduction ·doi:10.1093/humrep/den375

BACKGROUND: Activation of macrophages is central to the implantation of endometriosis (EM). We examined the hypothesis that macrophage depletion by intraperitoneal (IP) injection of liposomal alendronate (LA) could result in EM attenuation …